Skye Bioscience Inc.

Skye Bioscience Inc. We are a pharmaceutical company focused on unlocking the potential of the endocannabinoid system

Skye’s differentiated peripherally-restricted CB1 inhibitor, nimacimab, has the potential to address the challenges of c...
08/22/2025

Skye’s differentiated peripherally-restricted CB1 inhibitor, nimacimab, has the potential to address the challenges of current obesity treatments, reducing side effects, improving response rates, and providing longer-term weight loss.

Explore our work and the current treatment landscape here: https://ir.skyebioscience.com/

We’re committed to applying the best practices from drug design through manufacturing, with an ambitious goal of advanci...
08/20/2025

We’re committed to applying the best practices from drug design through manufacturing, with an ambitious goal of advancing new drug candidates to help with important unmet needs.

Learn more about our pipeline here: https://skyebioscience.com/

We’re committed to developing next-generation anti-obesity therapeutics to meet this unprecedented unmet need.Learn more...
08/15/2025

We’re committed to developing next-generation anti-obesity therapeutics to meet this unprecedented unmet need.

Learn more about the current obesity treatment landscape here:
https://skyebioscience.com/obesity/

The potential to address unmet needs in obesity has never been higher.By targeting well-proven biological pathways, we’r...
08/13/2025

The potential to address unmet needs in obesity has never been higher.

By targeting well-proven biological pathways, we’re continuing our work at Skye to meet these needs.

Explore our pipeline and current Phase 2a trials with nimacimab here: https://skyebioscience.com/

08/05/2025

While GLP-1s have been effective in reducing food intake, they only address one aspect of weight loss.

For it to be healthy and sustainable, where people can keep weight off instead of regaining it, we need to account for more than just energy intake.

Today, Puneet Arora, MD, MS, FACE, explores how we might improve obesity-related treatment and long-term positive health impacts through CB1 inhibition.

To learn more about CB1 inhibition, visit our website here: https://skyebioscience.com/obesity/

Skye will host a live webcast and conference call to discuss our second quarter 2025 financial results, taking place on ...
07/30/2025

Skye will host a live webcast and conference call to discuss our second quarter 2025 financial results, taking place on August 7th at 1:30PM PT.

To access the call or to explore our recent press releases, investor presentations, and more, please visit our website: https://ir.skyebioscience.com/

07/25/2025

Incretin therapies have created a breakthrough in obesity treatment.

This success has been driven by hunger suppression that leads to noticeable weight loss, not only reducing weight but also decreasing comorbidities like heart failure and chronic kidney disease.

However, halting treatment often results in regaining most or all of the weight. In our most recent video, Puneet Arora, MD, FACE, explores this challenge, the complexity of obesity, and the importance of having access to a range of interventions.

With the rate of obesity doubling in just 32 years, this growing population has diverse needs related to their condition...
07/22/2025

With the rate of obesity doubling in just 32 years, this growing population has diverse needs related to their condition and treatment.

Skye remains focused on new mechanisms and drugs that have the potential to enhance therapeutic approaches and improve health outcomes.

Explore our values, our team, and our commitment here: https://skyebioscience.com/our-company/

The increase in rates is impacting people of all ages, further cementing the need for better treatment, improved harm ...
07/17/2025

The increase in rates is impacting people of all ages, further cementing the need for better treatment, improved harm reduction, and healthier weight loss options.

Learn more about how Skye is dedicated to developing new treatments that help reduce excess body fat and improve metabolic health: https://ir.skyebioscience.com/

Address

San Diego, CA

Telephone

+18584100266

Website

Alerts

Be the first to know and let us send you an email when Skye Bioscience Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category